899 related articles for article (PubMed ID: 9693396)
21. Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system.
Suvisaari J; Lähteenmäki P
Contraception; 1996 Oct; 54(4):201-8. PubMed ID: 8922872
[TBL] [Abstract][Full Text] [Related]
22. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
Chi IC
Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
[TBL] [Abstract][Full Text] [Related]
23. Clinical performance of the TCu 380A and TCu 220C IUDs in four developing country family planning clinics.
Farr G; Amatya R; Betancourt JD; David M; Alfonso L; Dacalos E
Contraception; 1994 Nov; 50(5):417-29. PubMed ID: 7859451
[TBL] [Abstract][Full Text] [Related]
24. Intrauterine devices: an effective alternative to oral hormonal contraception.
Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
[TBL] [Abstract][Full Text] [Related]
25. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
[TBL] [Abstract][Full Text] [Related]
26. Postpartum IUDS: keys for success.
O'Hanley K; Huber DH
Contraception; 1992 Apr; 45(4):351-61. PubMed ID: 1516367
[TBL] [Abstract][Full Text] [Related]
27. Menstrual characteristics and ultrasonographic uterine cavity measurements predict bleeding and pain in nulligravid women using intrauterine contraception.
Kaislasuo J; Heikinheimo O; Lähteenmäki P; Suhonen S
Hum Reprod; 2015 Jul; 30(7):1580-8. PubMed ID: 25990577
[TBL] [Abstract][Full Text] [Related]
28. Intracervical and fundal administration of levonorgestrel for contraception: endometrial thickness, patterns of bleeding, and persisting ovarian follicles.
Pakarinen PI; Suvisaari J; Luukkainen T; Lähteenmäki P
Fertil Steril; 1997 Jul; 68(1):59-64. PubMed ID: 9207585
[TBL] [Abstract][Full Text] [Related]
29. Hormonal intrauterine devices.
Rybo G; Andersson K; Odlind V
Ann Med; 1993 Apr; 25(2):143-7. PubMed ID: 8489751
[TBL] [Abstract][Full Text] [Related]
30. Long-term contraception with the levonorgestrel 20 mcg/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study.
Sivin I; el Mahgoub S; McCarthy T; Mishell DR; Shoupe D; Alvarez F; Brache V; Jimenez E; Diaz J; Faundes A
Contraception; 1990 Oct; 42(4):361-78. PubMed ID: 2124179
[TBL] [Abstract][Full Text] [Related]
31. Menstrual blood loss, haemoglobin and ferritin concentration of Beijing women wearing steel ring, VCu 200, and TCu 220c IUDs.
Gao J; Zeng S; Sun BL; Wu SC; Dong J; Cong J; Zhu XH; Fan HM; Han LH; Xie Z
Contraception; 1986 Dec; 34(6):559-71. PubMed ID: 3829674
[TBL] [Abstract][Full Text] [Related]
32. Postpartum contraception.
Edelman DA; Goldsmith A; Shelton JD
Int J Gynaecol Obstet; 1981 Aug; 19(4):305-11. PubMed ID: 6119259
[TBL] [Abstract][Full Text] [Related]
33. Can intrauterine device removals for bleeding or pain be predicted at a one-month follow-up visit? A multivariate analysis.
Stanback J; Grimes D
Contraception; 1998 Dec; 58(6):357-60. PubMed ID: 10095972
[TBL] [Abstract][Full Text] [Related]
34. Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India.
Roy M; Hazra A; Merkatz R; Plagianos M; Alami M; Gaur LN; Aruldas K; Sussman H; Variano B; Sitruk-Ware R;
Contraception; 2020 Sep; 102(3):159-167. PubMed ID: 32360666
[TBL] [Abstract][Full Text] [Related]
35. An analysis of the personal reasons for discontinuing IUD use.
Petta CA; Amatya R; Farr G; Chi I
Contraception; 1994 Oct; 50(4):339-47. PubMed ID: 7813222
[TBL] [Abstract][Full Text] [Related]
36. [The acceptability of current contraceptive methods to adolescents].
Sotnikova EI; Dubnitskaia LV; Perminova SG
Akush Ginekol (Mosk); 1993; (3):26-30. PubMed ID: 8048682
[TBL] [Abstract][Full Text] [Related]
37. New IPPF statement on breastfeeding, fertility and post-partum contraception.
International Planned Parenthood Federation IPPF. International Medical Advisory Panel IMAP
IPPF Med Bull; 1990 Apr; 24(2):2-4. PubMed ID: 12316285
[TBL] [Abstract][Full Text] [Related]
38. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
Modesto W; Bahamondes MV; Bahamondes L
Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
[TBL] [Abstract][Full Text] [Related]
39. Fertility regulation in nursing women. IX. Contraceptive performance, duration of lactation, infant growth, and bleeding patterns during use of progesterone vaginal rings, progestin-only pills, Norplant implants, and Copper T 380-A intrauterine devices.
Díaz S; Zepeda A; Maturana X; Reyes MV; Miranda P; Casado ME; Peralta O; Croxatto HB
Contraception; 1997 Oct; 56(4):223-32. PubMed ID: 9408703
[TBL] [Abstract][Full Text] [Related]
40. Effective contraception with the levonorgestrel-releasing intrauterine device: 12-month report of a European multicenter study.
Luukkainen T; Allonen H; Haukkamaa M; Holma P; Pyörälä T; Terho J; Toivonen J; Batar I; Lampe L; Andersson K
Contraception; 1987 Aug; 36(2):169-79. PubMed ID: 3123132
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]